Inhibition of cytomegalovirus immediate early gene expression: A therapeutic option?

Antiviral Research

Volumn 49, Issue 3, 2001, Pages 129-145

  Scholz, Martin ^a   Doerr, Hans Wilhelm ^a   Cinatl, Jindrich ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Antiviral therapy; Cytomegalovirus; Immediate early gene expression; Immunopathomechanisms

Indexed keywords

ACICLOVIR; ALPHA AMANITIN; BENZIMIDAZOLE DERIVATIVE; CHEMOKINE; CIDOFOVIR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYTOKINE; DNA POLYMERASE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FOMIVIRSEN; FOSCARNET; GANCICLOVIR; GENE EXPRESSION MODULATOR 132; GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LOBUCAVIR; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTETIC ACID; PHOSPHOTRANSFERASE; PYROPHOSPHATE; SERINE PROTEINASE INHIBITOR; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1; VIRUS DNA;

ANGIOGENESIS; CYTOMEGALIC INCLUSION BODY DISEASE; DNA REPLICATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HOST CELL; HUMAN CYTOMEGALOVIRUS; IMMEDIATE EARLY GENE; IMMUNOMODULATION; PRIORITY JOURNAL; REVIEW; TRANSACTIVATION; TUMOR SUPPRESSOR GENE; VIRUS INHIBITION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS SHEDDING;

ANTIVIRAL AGENTS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; GENES, IMMEDIATE-EARLY; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOCOMPROMISED HOST; THIONUCLEOTIDES;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0035045993     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(01)00126-7     Document Type: Review

References (179)

1. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process
2. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells
3. Disruption of PML subnuclear domains by the acidic IE1 protein of human cytomegalovirus is mediated through interaction with PML and may modulate a RING finger-dependent cryptic transactivator function of PML
4. Disruption of PML-associated nuclear bodies by IE1 correlates with efficient early stages of viral gene expression and DNA replication in human cytomegalovirus infection
5. Induction of an endothelial cell growth factor by human cytomegalovirus infection of fibroblasts
6. Inhibition of human cytomegalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA
7. Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter
8. Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early region
9. New antivirals - Mechanism of action and resistance development
10. CXC chemokines in angiogenesis
11. Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis
12. Depletion of extracellular RANTES during human cytomegalovirus infection of endothelial cells
13. Up- and downregulation of lymphocyte infiltration through allogeneic endothelial cell monolayers
14. Effect of a specific iron chelating agent on animal models of inflammation
15. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: Withdrawal of chemokines from the environment of cytomegalovirus-infected cells
16. Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function
17. Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway
18. The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein
19. UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells
20. A subset of viral transcripts packaged within human cytomegalovirus particles
21. Activation of stress-activated MAP protein kinases up-regulates expression of transgenes driven by the cytomegalovirus immediate/early promoter
22. Cytomegalovirus and atherogenesis
23. The human cytomegalovirus 86-kilodalton major immediate-early protein interacts physically and functionally with histone acetyltransferase P/CAF
24. Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins
25. Human immunodeficiency virus type 1 gp120 stimulates cytomegalovirus replication in monocytes: Possible role of endogenous interleukin-8
26. Cytomegalovirus induction of interleukin-6 in lung fibroblasts occurs independently of active infection and involves a G protein and the transcription factor NF-κB
27. The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation
28. Human cytomegalovirus immediate-early 2 (IE2) protein can transactivate the human hsp70 promoter by alleviation of Dr1-mediated repression
29. Human cytomegalovirus ie1 transactivates the alpha promoter-enhancer via an 18-base-pair repeat element
30. Human cytomegalovirus ie2 negatively regulates a gene expression via a short target sequence near the transcription start site
31. In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: Relationship to clinical outcome
32. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease
33. Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus disease
34. Human cytomegalovirus DNA polymerase and antiviral drug resistance: Recent progress
35. Effects of desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells
36. In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate
37. In vitro inhibition of human cytomegalovirus replication by calcium trinatrium diethylenetriamine-pentaacetic acid (DTPA)
38. Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells
39. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells
40. Proinflammatory potential of cytomegalovirus infection: Specific inhibition of cytomegalovirus immediate-early expression in combination with antioxidants as a novel treatment strategy?
41. Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53
42. The antisense oligonucleotide ISIS 2922 prevents cytomegalovirus-induced upregulation of IL-8 and ICAM-1 in cultured human fibroblasts
43. Decreased neutrophil adhesion to human cytomegalovirus-infected retinal pigment epithelial cells is mediated by virus-induced up-regulation of fas ligand independent of neutrophil apoptosis
44. Cytomegalovirus infection decreases expression of thrombospondin-1 and 2 in cultured human retinal glial cells: Effects of antiviral agents
45. Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression
46. Functional roles of immediate early proteins encoded by the human cytomegalovirus UL36-38, UL115-119, TRS1/IRS1 and US3 loci
47. Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment
48. Human cytomegalovirus infection upregulates interleukin-8 gene expression and stimulates neutrophil transendothelial migration
49. The immediate early genes of human cytomegalovirus require only proximal promoter elements to upregulate expression of interleukin-1 beta
50. Antiviral agents that are active against CMV: Potential of cidofovir for the treatment of CMV and other virus infections
51. Fomivirsen: A viewpoint
52. Fomivirsen - A phosphorothioate oligonucleotide for the treatment of CMV retinitis
53. Human cytomegalovirus and human herpesvirus 6 genes that transform and transactivate
54. trans Activation of plasmid-borne promoters by adenovirus and several herpes group viruses
55. Human cytomegalovirus: Challenges opportunities and new drug development
56. Identification of domains within the human cytomegalovirus major immediate-early 86-kilodalton protein and the retinoblastoma protein required for physical and functional interaction with each other
57. Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus
58. Human cytomegalovirus immediate-early gene 2 protein interacts with itself and with several novel cellular proteins
59. The UL84 protein of human cytomegalovirus acts as a transdominant inhibitor of immediate-early-mediated transactivation that is able to prevent viral replication
60. The immediate early genes of human cytomegalovirus upregulate expression of the interleukin-2 and interleukin-2 receptor genes
61. Cytomegalovirus immediate early genes prevent the inhibitory effect of cyclosporin A on interleukin 2 gene transcription
62. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-alpha gene expression
63. Cytomegalovirus modulates interleukin-6 gene expression
64. Cytomegalovirus modulates transcription factors necessary for the activation of the tumor necrosis factor-α promoter
65. Immediate early gene 2 of human cytomegalovirus increases interleukin 2 receptor-alpha gene expression
66. Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer
67. Multiple sequence-specific transcription factors modulate cytomegalovirus enhancer activity in vitro
68. Specific interactions between transcription factors and the promoter-regulatory region of the human cytomegalovirus major immediate early gene
69. Interactions between cellular regulatory proteins and a unique sequence region in the human cytomegalovirus immediate-early promoter
70. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to bcl-2
71. Current antiviral therapy fails to prevent the pro-inflammatory effects of cytomegalovirus infection, whilst rendering infected cells relatively resistant to immune attack
72. Up-regulation of LFA3 and ICAM-1 on the surface of fibroblasts infected with cytomegalovirus
73. Is cytomegalovirus interstitial pneumonitis in transplant recipients an immunopathological condition?
74. Increased adherence of CD2 peripheral blood lymphocytes to cytomegalovirus-infected fibroblasts is blocked by anti LFA3 antibody
75. Cytomegalovirus-infected endothelial cells recruit neutrophils by the secretion of C-X-C chemokines and transmit virus by direct neutrophil-endothelial cell contact and during neutrophil transendothelial migration
76. Physiological and pathological roles of interleukin-6 in the central nervous system
77. CMV retinitis: Clinical experience with the metal chelator desferroxamine
78. The human cytomegalovirus 80-kilodalton but not the 72-kilodalton immediate-early protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID
79. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein
80. Phosphorylation of the human cytomegalovirus 86-kilodalton immediate-early protein IE2
81. Human cytomegalovirus immediate-early two protein region involved in negative regulation of the major immediate-early promoter
82. Interleukin 6 and its receptor: Ten years later
83. Human cytomegalovirus inhibits transcription of the CC chemokine MCP-1 gene
84. Cidofovir, a new agent with potent anti-herpesvirus activity
85. Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b
86. Elevated serum cytokines are associated with cytomegalovirus infection and disease in bone marrow transplant recipients
87. The functional importance of a cap site-proximal region of the human prointerleukin 1 beta gene is defined by viral protein trans-activation
88. Human cytomegalovirus immediate early interaction with host nuclear structures: Definition of an immediate transcript environment
89. Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis
90. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy
91. Alpha1-Antitrypsin Portland, a bioengineered serpin highly selective for furin: Application as an antipathogenic agent
92. A protein-based therapeutic for human cytomegalovirus infection
93. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains
94. The DNA-binding subunit of human transcription factor IID can interact with the TATA box as a multimer
95. Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain
96. Physical and functional interaction between the HCMV IE2 protein and the Wilm's tumor suppressor WT1
97. Regulation of expression of the IL-1 receptor antagonist (IL-1ra) gene by products of the human cytomegalovirus immediate early genes
98. Effect of desferrioxamine (DFO) and calcium trinatrium diethylenetriaminepentaacetic acid (DTPA) on rat cytomegalovirus replication in vitro and in vivo
99. Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient
100. High incidence of active cytomegalovirus infection among septic patients
101. Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB
102. A cis-acting element in the major immediate-early (IE) promoter of human cytomegalovirus is required for negative regulation by IE2
103. Transcriptional activation by the human cytomegalovirus immediate-early proteins: Requirements for simple promoter structures and interactions with multiple components of the transcription complex
104. TAF-like functions of human cytomegalovirus immediate-early proteins
105. Effects of human cytomegalovirus major immediate-early proteins in controlling the cell cycle and inhibiting apoptosis: Studies with ts13 cells
106. A strong negative transcriptional regulatory region between the human cytomegalovirus UL127 gene and the major immediate-early enhancer
107. Antiviral and immunomodulatory effects of desferrioxamine in cytomegalovirus-infected rat liver allografts with rejection
108. HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor
109. Reactivation and shedding of cytomegalovirus in astronauts during spaceflight
110. Regulation of human cytomegalovirus immediate-early gene expression
111. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis
112. Modulation of RANTES production by human cytomegalovirus infection of fibroblasts
113. Viral immediate-early proteins abrogate the modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear body disruption
114. Human cytomegalovirus mtrII oncoprotein binds to p53 and down-regulates p53-activated transcription
115. Human cytomegalovirus induces interleukin-8 production by a human monocytic cell line THP-1, through acting concurrently on AP-1 and NF-κB-binding sites of the interleukin-8 gene
116. The immediate early gene 1 product of human cytomegalovirus is sufficient for up-regulation of interleukin-8 gene expression
117. The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells
118. Enhanced (cytomegalovirus) viral replication associated with septic bacterial complications in liver transplant recipients
119. Regulation and tissue-specific expression of human cytomegalovirus
120. Chemokines and soluble adhesion molecules in renal transplant recipients with cytomegalovirus infection
121. Potent antiviral activity of an antisense oligonucleotide complementary to the intron-exon boundary of human cytomegalovirus genes UL36 and UL37
122. Cytomegalovirus encodes a potent alpha chemokine
123. Transactivation and autoregulation of gene expression by the immediate-early region 2 gene products of human cytomegalovirus
124. Stimulation of the human cytomegalovirus enhancer/promoter in HL-60 cells by TNF-alpha is mediated via induction of NF-κB
125. Human cytomegalovirus infection in transplant recipients: Role of TNF-alpha for reactivation and replication of human cytomegalovirus
126. A novel link between stress and human cytomegalovirus (HCMV) infection: Sympathetic hyperactivity stimulates HCMV activation
127. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate early antigens mediate protective immunity
128. Interleukin-1 beta induced transient diabetes mellitus in rats: A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus?
129. In vitro generation of human cytomegalovirus pp65 antigenemia, viremia, and leukoDNAemia
130. pIRS1 and pTRS1 are present in human cytomegalovirus virions
131. Characterization of the human cytomegalovirus irs1 and trs1 genes: A second immediate-early transcription unit within irs1 whose product antagonizes transcriptional activation
132. Regulation of human immunodeficiency virus type 1 and cytokine gene expression in myeloid cells by NF-kappa B/Rel transcription factors
133. NF-κB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation
134. Mycophenolate mofetil increases cytomegalovirus invasive organ disease in renal transplant patients
135. Cytomegalovirus- and interferon-related effects on human endothelial cells: Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-α
136. Lymphocytes induce enhanced expression of HLA class I antigens on cytomegalovirus-infected syngeneic human endothelial cells
137. Immunomodulatory properties of the metal chelators desferrioxamine and diethylenetriamine penta-acetic acid in vitro
138. Impact of oxidative stress on human cytomegalovirus replication and on cytokine-mediated stimulation of endothelial cells
139. Prophylaxis of cytomegalovirus disease in high risk patients
140. Immunomodulation and anti cytomegalovirus activity of antioxidant metal chelators
141. Expression of human leukocyte antigens class I and class II on cultured biliary epithelial cells after cytomegalovirus infection
142. Cytomegalovirus, oxidative stress and inflammation as interdependent pathomechanisms: Need for novel therapeutic strategies?
143. Cytomegalovirus-infected neuroblastoma cells exhibit augmented invasiveness mediated by beta1alpha5 integrin (VLA-5)
144. CREB and CREB-binding proteins play an important role in the IE2 86-kilodalton protein-mediated transactivation of the human cytomegalovirus 2.2-kilobase RNA promoter
145. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on cytomegalovirus-infected endothelial cells
146. Pharmaceutical intervention in the JAK/STAT signaling pathway
147. Human cytomegalovirus IE1 and IE2 proteins are mutagenic and mediate 'hit-and-run' oncogenic transformation in cooperation with the adenovirus E1A proteins
148. Pertussis toxin-sensitive G proteins as mediators of the signal transduction pathways activated by cytomegalovirus infection of smooth muscle cells
149. Crystal structures of human cytomegalovirus protease delineate a new target for antiherpes drug design
150. Synthesis and screening of small molecule libraries active in binding to DNA
151. Expression of human cytomegalovirus UL36 and UL37 genes is required for viral DNA replication
152. Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein
153. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis
154. Role of reactive oxygen intermediates in cytomegalovirus gene expression and in the response of human smooth muscle cells to viral infection
155. Aspirin attenuates cytomegalovirus infectivity and gene expression mediated by cyclooxygenase-2 in coronary artery smooth muscle cells
156. Detection of multiple viral DNA species in synovial tissue and fluid of patients with early arthritis
157. Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains
158. Regulation of human cytomegalovirus transcription
159. Induction of cytokines by human cytomegalovirus
160. Murine cytomegalovirus-associated pneumonitis in the lungs free of the virus
161. Participation of two human cytomegalovirus immediate early gene regions in transcriptional activation of adenovirus promoters
162. A 79 amino acid oncogene is responsible for human cytomegalovirus mtrII induced malignant transformation
163. Promoter-regulatory region of the major immediate-early gene of human cytomegalovirus
164. Treatment of CMV diseases
165. Intracellular thiol redox status affects rat cytomegalovirus infection of vascular cells
166. The interaction between human cytomegalovirus immediate-early gene 2 (IE2) protein and heterogeneous ribonucleoprotein A1
167. Human cytomegalovirus immediate early proteins upregulate endothelial p53 function
168. Cytomegalovirus IE2 protein stimulates interleukin 1beta gene transcription via tethering to Spi-1/PU.1
169. Disruption of PML-associated nuclear bodies mediated by the human cytomegalovirus major immediate early gene product
170. Targeting RNA with small molecules
171. UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression
172. Functional interaction between pleiotropic transactivator pUL69 of human cytomegalovirus and the human homolog of yeast chromatin regulatory protein SPT6
173. Site-specific inhibition of RNA polymerase II preinitiation complex assembly by human cytomegalovirus IE86 protein
174. Transcription factor Sp1 mediates cell-specific trans-activation of the human cytomegalovirus DNA polymerase gene promoter by immediate-early protein IE86 in glioblastoma U373MG cells
175. The IE2 regulatory protein of human cytomegalovirus induces expression of the human transforming growth factor beta1 gene through an Egr-1 binding site
176. Benefits of posttransplantation monitoring of interleukin 6 in lung transplantation
177. Three MDBP sites in the immediate-early enhancer-promoter region of human cytomegalovirus
178. The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor
179. Human cytomegalovirus IE1 and IE2 proteins block apoptosis